Plasma-derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.

Escobar, Miguel A; Kavakli, Kaan

Escobar, Miguel A; Kavakli, Kaan.

Affiliation

Escobar MA; University of Texas Health Science Center at Houston-McGovern Medical School and the Gulf States Hemophilia and Thrombophilia Center, Houston, Texas, USA.
Kavakli K; Department of Pediatrics, Division of Hemato-Oncology, Ege University Faculty of Medicine, Izmir, Turkey.

Haemophilia ; 30(1): 59-67, 2024 Jan.

Article in En | MEDLINE | ID: mdl-37902395

Subject(s)

Factor X Deficiency; Factor X; Humans; Factor X/therapeutic use; Factor X/adverse effects; Factor X Deficiency/complications; Factor X Deficiency/drug therapy; Prospective Studies; Retrospective Studies; Hemorrhage/etiology; Hemorrhage/prevention & control; Plasma

Key words

factor X deficiency; plasma-derived factor X; prothrombin complex concentrate; rare blood disorder; severe bleeding episode

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor X / Factor X Deficiency Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google